A Stem Cell-Based Clinical Trial for Retinitis Pigmentosa: Henry Klassen, UC Irvine
Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. In this video, UC-Irvine professor Henry Klassen describes a CIRM-funded project that aims to begin a stem cell-based clinical trial for RP in early 2015. See our fact sheet for more about CIRM-funded vision loss research. For a patient perspective on RP watch this video.
3D animated title courtesy of Ian Adair
Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.